Results 81 to 90 of about 1,973 (178)

Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study.

open access: yes, 2014
Objectives: To conduct a cost-effectiveness analysis of sevelamer versus calcium carbonate in patients with non-dialysis-dependent CKD (NDD-CKD) from the Italian NHS perspective using patient-level data from the INDEPENDENT-CKD study.
Bellasi A   +4 more
core   +1 more source

Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale

open access: yesGiornale di Clinica Nefrologia e Dialisi, 2015
non disponibile (Cardionephrology)
Luca Di Lullo   +6 more
doaj   +1 more source

Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study

open access: yes, 2015
The recent multicenter, randomized, open-label INDEPENDENT study demonstrated that sevelamer improves survival in new to hemodialysis (HD) patients compared with calcium carbonate.
Bell, Cynthia   +6 more
core   +1 more source

Sevelamer worsen metabolic acidosis in hemodialysis patients

open access: yes, 2006
Background: Sevelamer hydrochloride, a major phosphate binder for patients on maintenance hemodialysis (MHD) is associated with reduced serum bicarbonate concentration due to hydrochloric acid release in the gut and to the binding of short chain fatty ...
Cirillo M.   +13 more
core  

Analisi costo/efficacia di sevelamer nel trattamento dell’iperfosforemia del paziente in dialisi

open access: yes, 2004
Dialysis-associated hyperphosphatemia has been treated with chelating calcium salts, in particular with calcium carbonate. A new option for the management of this problem is represented by sevelamer, a chelating agent which contains no calcium and no ...
Barbone, Gaia Santagostino   +2 more
core   +1 more source

Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature

open access: yesBMC Nephrology, 2018
Background Although fatigue is common in dialysis patients, polypharmacy is seldom listed among its causes. In this report, we describe a dialysis patient who developed severe fatigue due to pharmacological interaction between two commonly prescribed ...
Emanuela Cataldo   +5 more
doaj   +1 more source

Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials

open access: yesKidney & Blood Pressure Research, 2018
Background/Aims: Hyperphosphatemia is common in patients on hemodialysis. The efficacy of lanthanum carbonate (LC) in the treatment of hyperphosphatemia in these patients remains controversial.
Fang Wang   +5 more
doaj   +1 more source

Cardiovascular Effects of Sevelamer in Stage 3 CKD

open access: yes, 2013
Serum phosphate independently predicts cardiovascular mortality in the general population and CKD, even when levels are in the normal range. Associations between serum phosphate, arterial stiffness, and left ventricular (LV) mass suggest a possible ...
Townend, Jonathan N   +8 more
core   +1 more source

The impact of sevelamer in aluminum phosphide poisoning: a preliminary study on mortality

open access: yesMedicina Clínica Práctica
Background: Aluminum phosphide (ALP) poisoning, commonly referred to as rice tablet poisoning, is among the deadliest forms of poisoning. Treatment for aluminum phosphide poisoning is limited to supportive care, as no specific antidote is currently ...
Kiandokht Khorshidi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy